Skip to main content

Peer Review reports

From: Paeoniflorin alleviates hypoxia/reoxygenation injury in HK-2 cells by inhibiting apoptosis and repressing oxidative damage via Keap1/Nrf2/HO-1 pathway

Original Submission
5 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
20 Apr 2022 Reviewed Reviewer Report
22 Jun 2023 Reviewed Reviewer Report - Megharani Mahajan
20 Aug 2023 Author responded Author comments - Hongli Zhou
Resubmission - Version 3
20 Aug 2023 Submitted Manuscript version 3
31 Aug 2023 Author responded Author comments - Hongli Zhou
Resubmission - Version 4
31 Aug 2023 Submitted Manuscript version 4
14 Sep 2023 Author responded Author comments - Hongli Zhou
Resubmission - Version 5
14 Sep 2023 Submitted Manuscript version 5
22 Sep 2023 Reviewed Reviewer Report
2 Oct 2023 Reviewed Reviewer Report - Megharani Mahajan
11 Oct 2023 Author responded Author comments - Hongli Zhou
Resubmission - Version 6
11 Oct 2023 Submitted Manuscript version 6
12 Oct 2023 Author responded Author comments - Hongli Zhou
Resubmission - Version 7
12 Oct 2023 Submitted Manuscript version 7
Publishing
13 Oct 2023 Editorially accepted
26 Oct 2023 Article published 10.1186/s12882-023-03366-0

You can find further information about peer review here.

Back to article page